Open AccessIs the coverage of mass-drug-administration adequate for elimination of Bancroftian filariasis? An experience from West Bengal, India
Author(s) -
Dibakar Haldar,
Debkumar Ghosh,
Dhruba Mandal,
Abhik Sinha,
Gautam Narayan Sarkar,
Sucharita Sarkar
Publication year - 2015
Publication title -
tropical parasitology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.418
H-Index - 11
eISSN - 2229-7758
pISSN - 2229-5070
DOI - 10.4103/2229-5070.149921
Subject(s) - mass drug administration , west bengal , bancroftian filariasis , filariasis , administration (probate law) , food and drug administration , medicine , drug , drug administration , lymphatic filariasis , wuchereria bancrofti , environmental health , socioeconomics , pharmacology , immunology , political science , economics , population , helminths , law
Bancroftian filariasis is the second most common mosquito-borne disease in India. Government of India adopted mass-drug-administration (MDA) since 2004 for its elimination by 2015 AD.